10 Best Day Trading Penny Stocks to Buy
Day trading penny stocks is not a normal buy-and-hold setup.
Compass Therapeutics Inc. (CMPX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 1,348,259 | $7,132,289 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.89 | 15,000 | $28,350.00 | 397,500 | 2026-04-29 | Filing | |
| $1.89 | 25,000 | $47,250.00 | 196,000 | 2026-04-29 | Filing | |
| $2.11 | 10,000 | $21,100.00 | 6,480,825 | 2025-05-27 | Filing | |
| $1.54 | 20,000 | $30,800.00 | 21,000 | 2025-04-07 | Filing | |
| $1.42 | 20,000 | $28,400.00 | 320,000 | 2025-04-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $4.36 | 2 | $8.72 | 1,060,414 | 2022-11-25 | Filing | |
| $4.30 | 9,569 | $41,146.70 | 1,060,416 | 2022-11-23 | Filing | |
| $4.19 | 14,929 | $62,552.51 | 1,069,985 | 2022-11-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,037,175 | $31,936,656 | 0% | |
| 2. | 2,391,333 | $12,650,151 | 0% | |
| 3. | 1,082,651 | $5,727,224 | 0% | |
| 4. | 998,140 | $5,280,161 | 0% | |
| 5. | 828,879 | $4,384,770 | 0.08% |
News See All
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended period of market uncertainty in the prior year, noting that market attention ...
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory
We came across a bullish thesis on Compass Therapeutics, Inc. on r/stocks by Cute_Confidence6033. In this article, we will summarize the bulls’ thesis on CMPX.
Compass Therapeutics' (CMPX) Tovecimig Drives Strong Analyst Sentiment
On December 3, 2025, Compass Therapeutics, Inc. (NASDAQ:CMPX) saw Canaccord analyst John Newman initiate coverage of the stock with a “Buy” rating and a $10 price target.
12 Best Multibagger Stocks to Buy Heading into 2026
As we head into 2026, the biggest question market participants are asking is whether the strong momentum this year can carry over into next year.
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement
On November 10, 2025, H.C. Wainwright’s Joseph Pantginis reiterated a “Buy” rating on Compass Therapeutics, Inc. (NASDAQ:CMPX) with a $24 price target.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development
Compass Therapeutics Inc. (NASDAQ:CMPX) is a must-buy penny stock to buy now. On November 10, Pipe Sandler analyst Biren Amin reiterated that Compass Therapeutics Inc.
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX)
Compass Therapeutics Inc. (NASDAQ:CMPX) is one of the best stocks under $5 with highest upside potential. Compass Therapeutics Inc.
Hedge Fund Resource Center